Soleno Therapeutics SLNO
$ 45.15
-0.11%
Quarterly report 2024-Q3
added 11-06-2024
Country |
USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
DR. Anish Bhatnagar |
Employees in the company |
13 |
Shares |
8.4 M |
Market Cap[1] |
$ 379 M |
EBITDA (LTM) |
$ -41.5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.